Yiman Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yiman Huang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aijun Chen
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
2 shared publications - Chao Wang
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
2 shared publications - Lishu Zheng
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
2 shared publications - Xiaocao Meng
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
2 shared publications - Dong Zhao
Shijiazhuang Center for Disease Control and Prevention Shijiazhuang China
1 shared publication - Enrui Guan
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
1 shared publication
Latest Publications
- 9 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70921
Dual‐Mode CRISPR/Cas13a Assay for the Detection of Human Metapneumovirus in Clinical Respiratory Samples
Human metapneumovirus (HMPV) is a significant pathogen, causing widespread acute respiratory infections (ARIs). Rapid and accurate detection is crucial for timely diagnosis and outbreak control. To address the limitations of real‐time reverse transcription quantitative polymerase chain reaction (RT‐qPCR)‐based HMPV detection, we developed a novel method integrating recombinase‐aided amplification (RAA) with CRISPR‐Cas13a technology. Based on the alignment of 335 HMPV whole‐genome sequences, a conserved region of the nucleocapsid ( N ) gene was selected for RAA primer and CRISPR RNA (crRNA) design. The concentrations of Cas protein, crRNA, and probe were optimized for specificity, sensitivity, and repeatability. A dual‐mode platform was established, combining a fluorescence assay for quantitative detection and a lateral flow assay (LFA) for visual, on‐site readout. Both methods were validated using 106 clinical samples and compared with RT‐qPCR. Both methods demonstrated high specificity (no cross‐reactivity with other respiratory viruses), a detection limit of 1 copy/μL, and excellent repeatability. Clinical validation showed complete concordance ( κ = 1, p < 0.001) between the fluorescence assay and RT‐qPCR, and high agreement for LFA ( κ = 0.924, p < 0.001), with a sensitivity of 94.23%, specificity of 98.15%, positive predictive value (PPV) of 98%, and negative predictive value (NPV) of 94.6%. This study presents an RAA‐CRISPR/Cas13a dual‐mode platform for HMPV detection, providing a robust molecular diagnostic framework that paves the way for the future development of rapid testing assays.
- 9 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70921
Dual‐Mode CRISPR/Cas13a Assay for the Detection of Human Metapneumovirus in Clinical Respiratory Samples
Human metapneumovirus (HMPV) is a significant pathogen, causing widespread acute respiratory infections (ARIs). Rapid and accurate detection is crucial for timely diagnosis and outbreak control. To address the limitations of real‐time reverse transcription quantitative polymerase chain reaction (RT‐qPCR)‐based HMPV detection, we developed a novel method integrating recombinase‐aided amplification (RAA) with CRISPR‐Cas13a technology. Based on the alignment of 335 HMPV whole‐genome sequences, a conserved region of the nucleocapsid ( N ) gene was selected for RAA primer and CRISPR RNA (crRNA) design. The concentrations of Cas protein, crRNA, and probe were optimized for specificity, sensitivity, and repeatability. A dual‐mode platform was established, combining a fluorescence assay for quantitative detection and a lateral flow assay (LFA) for visual, on‐site readout. Both methods were validated using 106 clinical samples and compared with RT‐qPCR. Both methods demonstrated high specificity (no cross‐reactivity with other respiratory viruses), a detection limit of 1 copy/μL, and excellent repeatability. Clinical validation showed complete concordance ( κ = 1, p < 0.001) between the fluorescence assay and RT‐qPCR, and high agreement for LFA ( κ = 0.924, p < 0.001), with a sensitivity of 94.23%, specificity of 98.15%, positive predictive value (PPV) of 98%, and negative predictive value (NPV) of 94.6%. This study presents an RAA‐CRISPR/Cas13a dual‐mode platform for HMPV detection, providing a robust molecular diagnostic framework that paves the way for the future development of rapid testing assays.
- 16 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70716
Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells
Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.
- 16 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70716
Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells
Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.